Wagner Bowman Management Corp decreased its stake in shares of Clorox Co. (NYSE:CLX) by 0.1% during the second quarter, Holdings Channel reports. The firm owned 1,922 shares of the company’s stock after selling 1 shares during the period. Wagner Bowman Management Corp’s holdings in Clorox were worth $266,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank acquired a new position in Clorox during the fourth quarter valued at approximately $98,583,000. Chevy Chase Trust Holdings Inc. boosted its position in Clorox by 0.9% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 130,696 shares of the company’s stock valued at $16,476,000 after buying an additional 1,193 shares during the period. Woodley Farra Manion Portfolio Management Inc. boosted its position in Clorox by 6.3% in the first quarter. Woodley Farra Manion Portfolio Management Inc. now owns 17,591 shares of the company’s stock valued at $2,218,000 after buying an additional 1,041 shares during the period. Davis R M Inc. boosted its position in Clorox by 8.9% in the first quarter. Davis R M Inc. now owns 7,600 shares of the company’s stock valued at $958,000 after buying an additional 618 shares during the period. Finally, Private Trust Co. NA boosted its position in Clorox by 137.8% in the first quarter. Private Trust Co. NA now owns 4,088 shares of the company’s stock valued at $515,000 after buying an additional 2,369 shares during the period. Institutional investors own 70.26% of the company’s stock.

Shares of Clorox Co. (NYSE:CLX) traded up 0.79% on Wednesday, hitting $124.41. The stock had a trading volume of 683,221 shares. Clorox Co. has a 52 week low of $113.37 and a 52 week high of $140.47. The firm has a 50 day moving average price of $129.33 and a 200-day moving average price of $130.06. The company has a market cap of $16.11 billion, a price-to-earnings ratio of 25.29 and a beta of 0.33.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. The business earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period last year, the business earned $1.44 EPS. Analysts anticipate that Clorox Co. will post $5.49 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be issued a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is currently 64.91%.

CLX has been the topic of several research reports. Jefferies Group reissued a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. B. Riley reissued a “neutral” rating and set a $109.00 price target on shares of Clorox in a research report on Tuesday, August 9th. Atlantic Securities initiated coverage on Clorox in a research report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 price target on the stock. Deutsche Bank AG reissued a “hold” rating and set a $134.00 price target (up from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Finally, Zacks Investment Research lowered Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday, July 5th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $128.90.

In other news, EVP Laura Stein sold 38,882 shares of Clorox stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the sale, the executive vice president now owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jon M. Balousek sold 5,136 shares of Clorox stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the sale, the senior vice president now directly owns 15,384 shares in the company, valued at approximately $2,017,457.76. The disclosure for this sale can be found here. 2.09% of the stock is owned by company insiders.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.